lutetium (177lu) vipivotide tetraxetan
ItalyDrugs containing this active substance
-
It is used to treat adults with a specific type of prostate cancer (progressive castration-resistant prostate cancer) that has spread to other parts of the body and has already undergone other anticancer treatments.
Form: solution for injection or infusion
Active substance Dosage lutetium (177lu) vipivotide tetraxetan - ATC: V10XX05
Manufacturer: NOVARTIS EUROPHARM LIMITED